Donna Yu
Impact in
- Hepatology top 2%
- Liver Diseases and Immunity
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 12
- Drug Transport and Resistance Mechanisms 11
- Cytokine Signaling Pathways and Interactions 3
-
- Receptor Mechanisms and Signaling 3
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- Barry M. Forman (13 shared papers)Wendong Huang (11 shared papers)Yan‐Dong Wang (7 shared papers)Wei‐Dong Chen (2 shared papers)Weidong Chen (4 shared papers)Meihua Wang (1 shared paper)Lisheng Zhang (2 shared papers)Jia Su (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry (6 papers)Hepatology (4 papers)Oncotarget (2 papers)The Journal of Organic Chemistry (1 paper)Steroids (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Donna Yu
18 papers receiving 1.7k citations
Donna Yu's Hit Papers
Peers
Comparison fields: 5 of 86
- Hepatology 254
- Oncology 804
- Epidemiology 498
- Pharmacology 100
- Surgery 457
Countries citing papers authored by Donna Yu
This map shows the geographic impact of Donna Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Yu more than expected).
Fields of papers citing papers by Donna Yu
This network shows the impact of papers produced by Donna Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Yu. The network helps show where Donna Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Donna Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response Hit paper breakdown → | 2008 | 525 |
| 2 | 2011 | 401 | |
| 3 | 2016 | 158 | |
| 4 | 2009 | 98 | |
| 5 | 2015 | 79 | |
| 6 | 2014 | 70 | |
| 7 | 2005 | 63 | |
| 8 | 2015 | 46 | |
| 9 | 2003 | 37 | |
| 10 | 2011 | 32 | |
| 11 | 2014 | 31 | |
| 12 | 2015 | 31 | |
| 13 | 2017 | 30 | |
| 14 | 2013 | 22 | |
| 15 | 2012 | 19 | |
| 16 | 2016 | 19 | |
| 17 | 2017 | 14 | |
| 18 | 2021 | 2 |
About Donna Yu
Donna Yu is a scholar working on Oncology, Molecular Biology, Genetics, Surgery and Pharmacology, having authored 18 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Estrogen and related hormone effects (6 papers), Inflammatory mediators and NSAID effects (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Receptor Mechanisms and Signaling (3 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Hepatology (254 citations), Oncology (804 citations), Epidemiology (498 citations), Pharmacology (100 citations) and Surgery (457 citations). Donna Yu has collaborated with scholars based in United States and China. Frequent co-authors include Barry M. Forman, Wendong Huang, Yan‐Dong Wang, Wei‐Dong Chen, Weidong Chen, Meihua Wang, Lisheng Zhang, Jia Su, Wenwei Lin and Taosheng Chen. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Hepatology, Oncotarget, The Journal of Organic Chemistry and Steroids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.